Clinical trial
Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
NCT05885607 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Early Metabolic Adaptations to SGLT2 Inhibition in Heart Failure
- Lead sponsor
- University of Pennsylvania
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- June 27, 2023
- Completion date
- June 30, 2027
- Enrollment
- 40 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
heart failure, heart failure nyha class ii, heart failure nyha class iii